This site uses cookies, including third-party cookies, that help us to provide and improve our services. Privacy Policy

Professionals 213 Users Online

Selective D2 Antagonist Market

Selective D2 antagonist market - Global Industry Analysis 2014 - 2018 and Forecast 2019 - 2029

Selective D2 antagonist market

Market Overview

Selective D2 antagonist is a class of dopamine antagonist drug type which blocks the dopamine receptor by a process called receptor antagonism. Most of the D2 antagonist are antipsychotics drugs which are helpful in treating mental disorders like schizophrenia, bipolar disorders, etc. These D2 receptors are found in several part of the body such as substantia nigra, hypothalamus, striatum, cortex, etc.

There is high demand of selective D2 antagonist drugs due to increasing cases of mental disorders and depression. Market players are trying to expand the therapeutic application of selective D2 antagonist drugs thus creating more opportunity and scope for the growth of the selective D2 antagonist market in the future.

Rising prevalence rate of mental disorders like schizophrenia and bipolar disorders are major factors driving growth of the selective D2 antagonist market.  Expanding therapeutic use of these drugs by key market players are further expected to aid in the growth of the selective D2 antagonist market. The increasing awareness of people towards mental health is further anticipated to boost in growth of the selective D2 antagonist market.

High investment in research and development of these selective D2 antagonist drugs are further expected to fuel the growth of the selective D2 antagonist market. Increasing cases of depression and other mental illness may surge in the growth of the selective D2 antagonist market. However, there are several side effects associated with the use of selective D2 antagonist drugs which in turn hamper the growth of the selective D2 antagonist market.

Sample Report

FREE Report Sample is Available

In-depth report coverage is now just a few seconds away

Download PDF Get FREE Report Sample

Market Segmentation

Drug Class
  • Droperidol
  • Metoclopramide
  • Paliperidone palmitate
  • Lurasidone hydrochloride
  • Tiapride
  • Haloperidol
  • Asenapine
  • Chlorpromazine
  • Aripiprazole
  • Risperidone
  • Others
  • Schizophrenia
  • Bipolar disorder
  • Dementia
  • Unipolar depression
  • Others
route of administration
  • Oral route administration
  • Intravenous
  • intramuscular
distribution channel
  • Hospital pharmacies
  • Retail pharmacy
  • Drug stores
  • online
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa
Custom Report Cover

Make This Report Your Own

Take Advantage of Intelligence Tailored to your Business Objective

> Get a Customized Version

The report covers exhaustive analysis

  • Selective D2 Antagonist Market Segments
  • Selective D2 Antagonist Market Dynamics
  • Historical Actual Market Size, 2013 - 2017
  • Selective D2 Antagonist Market Size & Forecast 2018 to 2024
  • Market Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Market Drivers and Restraints 
Market Research Methodology

Market Research Methodology

-Perfect through Years of Diligence

Check Research Methodology

Report Highlights

  • Shifting Industry dynamics
  • In-depth market segmentation
  • Historical, current and projected industry size recent industry trends
  • Key Competition landscape
  • Strategies for key players and product offerings
  • Potential and niche segments/regions exhibiting promising growth
  • A neutral perspective towards market performance
Prerna Shiv

Prerna Shiv
Client Partner

Let's Connect

Conect me to identify wining opportunities

Ask An Expert
I'm Available

- Companies Covered in This Report -

Google translate